CO-EVOLVED MEDICINES Trademark

Trademark Overview

On Tuesday, December 8, 2020, a trademark application was filed for CO-EVOLVED MEDICINES with the United States Patent and Trademark Office. The USPTO has given the CO-EVOLVED MEDICINES trademark a serial number of 90366020. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, July 9, 2024. This trademark is owned by Empress Therapeutics, Inc.. The CO-EVOLVED MEDICINES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
co-evolved medicines

General Information

Serial Number90366020
Word MarkCO-EVOLVED MEDICINES
Filing DateTuesday, December 8, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, July 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 16, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
NOT AVAILABLE"MEDICINES"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmpress Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameEmpress Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Friday, December 11, 2020NEW APPLICATION ENTERED
Wednesday, June 2, 2021NON-FINAL ACTION E-MAILED
Friday, February 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 27, 2021ASSIGNED TO EXAMINER
Wednesday, June 2, 2021NON-FINAL ACTION WRITTEN
Wednesday, June 2, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 7, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 7, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 7, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 7, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 16, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, July 7, 2022SOU EXTENSION 1 FILED
Tuesday, January 11, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 7, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 7, 2022SOU EXTENSION 1 GRANTED
Tuesday, January 3, 2023SOU EXTENSION 2 GRANTED
Saturday, July 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 3, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 3, 2023SOU EXTENSION 2 FILED
Thursday, January 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 6, 2023SOU EXTENSION 3 FILED
Thursday, July 6, 2023SOU EXTENSION 3 GRANTED
Thursday, July 6, 2023SOU TEAS EXTENSION RECEIVED
Saturday, July 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 4, 2024SOU TEAS EXTENSION RECEIVED
Saturday, January 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2024SOU EXTENSION 5 FILED
Tuesday, July 9, 2024SOU EXTENSION 5 GRANTED
Thursday, January 4, 2024SOU EXTENSION 4 FILED
Thursday, January 4, 2024SOU EXTENSION 4 GRANTED

Related Keywords

medicines evolved disorders diseases related endocrinological metabolic neurodegenerative neurological system immune therapeutic